
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 775
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 775
Showing 1-25 of 775 citing articles:
Mitochondrial control of inflammation
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 159-173
Open Access | Times Cited: 524
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 159-173
Open Access | Times Cited: 524
Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 506
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 506
The epidemiology of Parkinson's disease
Yoav Ben‐Shlomo, Sirwan K.L. Darweesh, Jorge J. Llibre‐Guerra, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 283-292
Closed Access | Times Cited: 283
Yoav Ben‐Shlomo, Sirwan K.L. Darweesh, Jorge J. Llibre‐Guerra, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 283-292
Closed Access | Times Cited: 283
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 202
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 202
Microglia Mediated Neuroinflammation in Parkinson’s Disease
Sevim Işık, Kiyak Bercem Yeman, Rumeysa Akbayir, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1012-1012
Open Access | Times Cited: 110
Sevim Işık, Kiyak Bercem Yeman, Rumeysa Akbayir, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1012-1012
Open Access | Times Cited: 110
Exosomes based strategies for brain drug delivery
Fawad Ur Rehman, Yang Liu, Meng Zheng, et al.
Biomaterials (2022) Vol. 293, pp. 121949-121949
Closed Access | Times Cited: 108
Fawad Ur Rehman, Yang Liu, Meng Zheng, et al.
Biomaterials (2022) Vol. 293, pp. 121949-121949
Closed Access | Times Cited: 108
α-Synuclein in synaptic function and dysfunction
Manu Sharma, Jacqueline Burré
Trends in Neurosciences (2022) Vol. 46, Iss. 2, pp. 153-166
Open Access | Times Cited: 91
Manu Sharma, Jacqueline Burré
Trends in Neurosciences (2022) Vol. 46, Iss. 2, pp. 153-166
Open Access | Times Cited: 91
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4176-4176
Open Access | Times Cited: 89
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4176-4176
Open Access | Times Cited: 89
Bioinspired shark skin-based liquid metal triboelectric nanogenerator for self-powered gait analysis and long-term rehabilitation monitoring
Cheng Yeh, Fu‐Cheng Kao, Po‐Han Wei, et al.
Nano Energy (2022) Vol. 104, pp. 107852-107852
Closed Access | Times Cited: 73
Cheng Yeh, Fu‐Cheng Kao, Po‐Han Wei, et al.
Nano Energy (2022) Vol. 104, pp. 107852-107852
Closed Access | Times Cited: 73
Perspective on the current state of the LRRK2 field
Jean‐Marc Taymans, Matt Fell, Tim Greenamyre, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Jean‐Marc Taymans, Matt Fell, Tim Greenamyre, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration
Joseph D. Quick, Cristian Silva, Jia Hui Wong, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 57
Joseph D. Quick, Cristian Silva, Jia Hui Wong, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 57
Metabolic reprogramming and polarization of microglia in Parkinson’s disease: Role of inflammasome and iron
Haiyang Yu, Qing Chang, Tong Sun, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102032-102032
Closed Access | Times Cited: 55
Haiyang Yu, Qing Chang, Tong Sun, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102032-102032
Closed Access | Times Cited: 55
Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 54
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 54
The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease
Aurélie de Rus Jacquet, Melanie Alpaugh, Hélèna L. Denis, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 53
Aurélie de Rus Jacquet, Melanie Alpaugh, Hélèna L. Denis, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 53
The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation
Mohammad Sobhan Karvandi, Farzam Sheikhzadeh Hesari, Amir Reza Aref, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 45
Mohammad Sobhan Karvandi, Farzam Sheikhzadeh Hesari, Amir Reza Aref, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 45
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease
Shruti Rajan, Kamatham Pushpa Tryphena, Sabiya Samim Khan, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101915-101915
Closed Access | Times Cited: 42
Shruti Rajan, Kamatham Pushpa Tryphena, Sabiya Samim Khan, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101915-101915
Closed Access | Times Cited: 42
Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes
Junpeng Yang, Xueli Yang, Guojun Wu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1548-1562.e7
Open Access | Times Cited: 40
Junpeng Yang, Xueli Yang, Guojun Wu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1548-1562.e7
Open Access | Times Cited: 40
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 40
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 40
Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial
Arnout Bruggeman, Charysse Vandendriessche, Hannelore Hamerlinck, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102563-102563
Open Access | Times Cited: 30
Arnout Bruggeman, Charysse Vandendriessche, Hannelore Hamerlinck, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102563-102563
Open Access | Times Cited: 30
Parkinson’s Disease
Caroline M. Tanner, Jill L. Ostrem
New England Journal of Medicine (2024) Vol. 391, Iss. 5, pp. 442-452
Closed Access | Times Cited: 30
Caroline M. Tanner, Jill L. Ostrem
New England Journal of Medicine (2024) Vol. 391, Iss. 5, pp. 442-452
Closed Access | Times Cited: 30
Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
Paras Mani Giri, Anurag Banerjee, Arpita Ghosal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3995-3995
Open Access | Times Cited: 28
Paras Mani Giri, Anurag Banerjee, Arpita Ghosal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3995-3995
Open Access | Times Cited: 28
Key genes and convergent pathogenic mechanisms in Parkinson disease
Robert Coukos, Dimitri Krainc
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 6, pp. 393-413
Closed Access | Times Cited: 25
Robert Coukos, Dimitri Krainc
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 6, pp. 393-413
Closed Access | Times Cited: 25
The role of NLRP3 inflammasome in aging and age-related diseases
Ruikai Liang, Xinrui Qi, Qi Cai, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Ruikai Liang, Xinrui Qi, Qi Cai, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 18
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 18